1. Home
  2. ESPR vs LIND Comparison

ESPR vs LIND Comparison

Compare ESPR & LIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$2.65

Market Cap

793.7M

Sector

Health Care

ML Signal

HOLD

Logo Lindblad Expeditions Holdings Inc.

LIND

Lindblad Expeditions Holdings Inc.

HOLD

Current Price

$18.19

Market Cap

899.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESPR
LIND
Founded
2008
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Transportation Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
793.7M
899.2M
IPO Year
2013
2011

Fundamental Metrics

Financial Performance
Metric
ESPR
LIND
Price
$2.65
$18.19
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
4
Target Price
$7.60
$22.25
AVG Volume (30 Days)
4.6M
755.6K
Earning Date
03-10-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
60.71
5.97
EPS
N/A
N/A
Revenue
$403,135,000.00
N/A
Revenue This Year
$0.69
$10.55
Revenue Next Year
$10.67
$6.34
P/E Ratio
N/A
N/A
Revenue Growth
21.31
N/A
52 Week Low
$0.73
$7.45
52 Week High
$4.18
$21.23

Technical Indicators

Market Signals
Indicator
ESPR
LIND
Relative Strength Index (RSI) 40.23 51.36
Support Level $2.37 $11.27
Resistance Level $3.02 $21.23
Average True Range (ATR) 0.20 0.82
MACD -0.00 -0.08
Stochastic Oscillator 38.52 64.09

Price Performance

Historical Comparison
ESPR
LIND

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

About LIND Lindblad Expeditions Holdings Inc.

Lindblad Expeditions Holdings Inc provides expedition cruising and adventure travel services. The company operates in two segments: Lindblad and Land Experiences, of which Lindblad generates the vast majority of its revenue. It offers itineraries that feature up-close encounters with wildlife, nature, history, and culture, as well as promote guest empowerment and interactivity. It operates expeditions on intimately-scaled ships and interaction between guests, crew, and the teams of scientists, naturalists, researchers, and photographers that participate in the expeditions. Lindblad operates a fleet of twelve owned expedition ships and five seasonal charter vessels under the Lindblad brand.

Share on Social Networks: